General Fusion and Kyoto Fusioneering Sign MOU to Accelerate Commercialization of Magnetized Target Fusion
October 11, 2023 09:00 ET
|
General Fusion
RICHMOND, British Columbia and TOKYO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Today, General Fusion and Kyoto Fusioneering announced a Memorandum of Understanding (MOU) to accelerate the commercialization...
Linarc Named to Construction Executive Magazine’s 2023 Top Technology Construction Firms
October 10, 2023 08:00 ET
|
Linarc
Los Angeles, Calif., United States, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Linarc, Inc., the fastest growing collaborative project management platform in the construction industry, today announced that...
SENTALER Launches New Fall Winter 2023/24 Men’s Collection with John Tavares Collaboration
September 29, 2023 05:00 ET
|
SENTALER
TORONTO, Ontario, Canada, Sept. 29, 2023 (GLOBE NEWSWIRE) -- SENTALER, the renowned luxury Canadian outerwear brand, has launched its new Fall Winter 2023/24 men’s collection and an exclusive...
Warpath and Metal Slug 3 Explode onto the Battlefield with a Brand New Collaboration
September 28, 2023 09:00 ET
|
Lilith Games
SHANGHAI, China, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Today, Lilith Games is excited to announce that Warpath, the free-to-play competitive RTS game available on PC, iOS, and Android devices, is...
Freshworks Customers Using Microsoft Teams Increase Employee Experience and Productivity
September 28, 2023 08:00 ET
|
Freshworks Inc
SAN MATEO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) announced a significant increase in Microsoft Teams usage by Freshservice® customers to improve the employee...
BioNTech und CEPI geben Partnerschaft zur Entwicklung eines mRNA-Mpox-Impfstoffs und zur Unterstützung von CEPIs 100-Tage-Ziel bekannt
September 18, 2023 06:45 ET
|
BioNTech SE
BioNTech bereitet klinische Phase-1/2-Studie für das mRNA-basierte Mpox-Impfstoffprogramm BNT166 vorDie Coalition for Epidemic Preparedness Innovations (CEPI) stellt bis zu 90 Millionen US-Dollar für...
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
September 18, 2023 06:45 ET
|
BioNTech SE
BioNTech is initiating a Phase 1/2 clinical trial of the mRNA-based mpox vaccine program, BNT166The Coalition for Epidemic Preparedness Innovations (CEPI) commits funding of up to $90 million for the...
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
September 13, 2023 08:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive...
Protein Industries Canada and Innovate UK Announce Joint Call for Plant-Based Food and Ingredient R&D Projects
September 12, 2023 12:00 ET
|
Protein Industries Canada
Edmonton, Alta., Sept. 12, 2023 (GLOBE NEWSWIRE) -- The bilateral partnership between Protein Industries Canada, one of Canada’s five Global Innovation Clusters, and Innovate UK, the UK’s national...
Salipro Biotech enters into research collaboration with Sumitomo Pharma to advance a drug discovery program
September 12, 2023 02:00 ET
|
Salipro Biotech AB
The collaboration leverages Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilize a challenging drug target to investigate the pharmacological characteristics of a...